Table 5.
Estimated risk (%) for each case of preeclampsia for each model at a fixed FPR of 10%
| Cases ID | PAPP-A + Inhibin A | PAPP-A + sFlt-1/PlGF 1 | PAPP-A + sFlt-1/PlGF 2 | BMI + sFlt-1 1 | sFlt-1/PlGF 1 + sFlt-1/PlGF 2 | Pattern* | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| 38 |
4.43 |
2.59 |
55.44 |
0.79 |
7.25 |
0 |
0 |
1 |
0 |
1 |
| 51 |
18.64 |
4.76 |
2.62 |
5.30 |
0.64 |
1 |
1 |
1 |
1 |
0 |
| 147 |
2.86 |
5.40 |
1.62 |
51.4 |
19.85 |
0 |
1 |
0 |
1 |
1 |
| 137 |
36.53 |
33.60 |
38.30 |
19.1 |
31.95 |
1 |
1 |
1 |
1 |
1 |
| 144 |
2.96 |
36.02 |
3.11 |
42.9 |
20.90 |
0 |
1 |
1 |
1 |
1 |
| 4 |
0.59 |
99.32 |
1.88 |
40.3 |
97.83 |
0 |
1 |
0 |
1 |
1 |
| 218 |
5.46 |
99.99 |
80.35 |
20.8 |
99.99 |
1 |
1 |
1 |
1 |
1 |
| 153 | 26.96 | 100 | 99.92 | 30.6 | 100 | 1 | 1 | 1 | 1 | 1 |
*0 = missed case, 1 = detected case.
PAPP-A: pregnancy-associated plasma protein-A, sFlt-11: second trimester sFlt-1, PlGF1: second trimester PlGF, sFlt-1/PlGF1: second trimester sFlt-1/PlGF ratio, sFlt-12: third trimester sFlt-1, PlGF2: third trimester PlGF, sFlt-1/PlGF2: third trimester sFlt-1/PlGF ratio.